Anteris Technologies Global Corp. Common Stock

Anteris Technologies Global Corp. is a structural heart company that develops and commercializes minimally invasive medical devices for heart valve diseases. Its products include the DurAVR transcatheter heart valve system, a transcatheter aortic valve for severe aortic stenosis designed to mimic a healthy human aortic valve; ADAPT anti-calcification tissue, a preparation that turns xenograft tissue into durable bioscaffolds for surgical repair in settings such as aortic valve replacement; and the ComASUR delivery system, a balloon expandable system with a reinforced steerable catheter for controlled deflection through the heart anatomy. The company is based in Toowong, Australia.